癌症免疫的要素和癌症免疫设定点
1Genentech, 1 DNA Way, South San Francisco, California 94080, USA.
Nature
|January 20, 2017
概括
免疫疗法对癌症治疗具有前景,但长期反应有限. 了解瘤,宿主和环境所影响的癌症免疫设定点是改善患者结果的关键.
科学领域:
- 癌症学
- 免疫学
- 癌症研究
背景情况:
- 免疫疗法,特别是针对CTLA4和PD-L1/PD-1的抗体,是一种有效的癌症治疗方法.
- 只有少数患者对当前免疫疗法有持久反应.
- 需要全面了解癌症免疫力,
研究的目的:
- 探索影响抗癌免疫反应的多方面因素.
- 确定可以预测患者对免疫治疗反应的免疫特征.
- 引入"癌症免疫设定点"的概念作为一个人的固有免疫状态.
主要方法:
- 对定义预测性免疫特征的临床研究进行审查.
- 癌症免疫周期的分析.
- 瘤,宿主和环境因素的整合.
主要成果:
- 癌症免疫力是由瘤,宿主和环境因素的复杂相互作用决定的.
- 这些因素共同决定了抗癌反应的强度和时间.
- 免疫特征正在成为免疫治疗反应的预测因素.
结论:
- "癌症免疫设定点"包含一个人关于癌症的整体免疫状态.
- 为了提高免疫疗法的有效性,需要对癌症免疫力进行更广泛的研究.
- 识别和描述癌症免疫设定点可能会导致更个性化的治疗策略.
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Stem Cells and Tumor Maintenance
6.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Cytotoxic T Cells-mediated Immune Response
7.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K


